Trevor CrosseBSc


Solicitor (UK)

Offices: London (UK)

Languages spoken: English


Telephone (Direct): +44 20 7420 0276

Telephone (Office): +44 20 7420 0250

Download vCard


Trevor Crosse

Trevor is an intellectual property lawyer who advises clients on the commercialisation and enforcement of their IP rights, with a particular focus on patent and licensing disputes in the biotechnology and pharmaceutical sectors. His primary expertise lies in biopharmaceutical patent and SPC litigation, in which he regularly advises clients in relation to complex technical disputes.

Trevor has advised clients on actions in the High Court, Court of Appeal and Intellectual Property Enterprise Court, as well as in relation to references to the Court of Justice of the European Union. His work routinely involves multi-jurisdictional disputes and he has significant experience co-ordinating global litigation strategies for his clients.

Trevor qualified as a solicitor in 2009 and joined Marks & Clerk Law in 2010. He became a partner of the firm in 2019.

Trevor has been recognised as a rising star by Managing Intellectual Property, IP Stars, 2018.
Educational Qualifications

Postgraduate Diploma in Intellectual Property Law and Practice, Oxford University (2012)

Qualified as a Solicitor in England & Wales (2009)

Legal Practice Course, College of Law, Birmingham (2006)

Graduate Diploma in Law, College of Law, Birmingham (2005)

BSc Microbiology with Immunology, University of Leeds (2003)
Example Cases

Eli Lilly v Genentech (Anti-IL17A/F antibodies)

Chugai Pharmaceutical Co v UCB Pharma (Antibody humanisation protocols)

Fujifilm Kyowa Kirin Biologics v AbbVie (Humira therapy for Crohn’s disease)

Fujifilm Kyowa Kirin Biologics v AbbVie (Humira dosing regimen)

Hospira UK v Genentech (Herceptin combination therapy)

Hospira UK v Genentech (Herceptin formulation)

Hospira UK v Genentech (Herceptin dosing regimen)

Regeneron Pharmaceuticals v Genentech (VEGF antagonists)

MedImmune v Novartis (Phage display)

Trevor Crosse works in the following sectors

Mechanical Engineering
Medical devices

Supreme Court Decision: Regeneron v Kymab

Latest instalment in long-running global patent dispute

POSTED 29 June 2020

You may also be interested in...

Litigate, arbitrate or mediate?

Litigate, arbitrate or mediate?

Why choose one option over another?  And how will the structured procedure of litigation affect case preparation?

Our news

Marks & Clerk is very proud to be celebrating 100 years in Canada

POSTED 4 January 2021

Regeneron Recast – Mr Justice Birss provides illuminating insight into the law of sufficiency

POSTED 27 January 2021

Find the right person

Find the office that suits you

Click here to view our offices